» Articles » PMID: 23422835

MAIT Cells, Surveyors of a New Class of Antigen: Development and Functions

Overview
Publisher Elsevier
Date 2013 Feb 21
PMID 23422835
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

Mucosal associated invariant T (MAIT) cells are evolutionarily conserved T cells that are restricted by the non-classical MHC-1b molecule, MR1. MAIT cells are selected on hematopoietic cells, and exit the thymus with a naïve phenotype before expanding in the periphery and attaining a memory phenotype. MAIT cells represent an abundant oligoclonal population in human blood and liver. MAIT cells react against a newly identified class of antigens: vitamin B metabolites, which are found in most bacteria and yeasts. MAIT cells secrete IFN-γ and IL-17 and their frequencies are modified in several diseases. The specificity, evolutionary conservation and unique features of MAIT cells indicate important functions, either against a ubiquitous pathogen or in gut immune/epithelial homeostasis.

Citing Articles

Dysfunction and regulatory interplay of T and B cells in chronic hepatitis B: immunotherapy and emerging antiviral strategies.

Yu F, Zhu Y, Li S, Hao L, Li N, Ye F Front Cell Infect Microbiol. 2024; 14:1488527.

PMID: 39717542 PMC: 11663751. DOI: 10.3389/fcimb.2024.1488527.


Inflammation and Microbial Translocation Correlate with Reduced MAIT Cells in People with HIV.

Ryu A, Clagett B, Freeman M Pathog Immun. 2024; 10(1):19-46.

PMID: 39635460 PMC: 11613984. DOI: 10.20411/pai.v10i1.746.


Blocking Superantigen-Mediated Diseases: Challenges and Future Trends.

Wang P, Fredj Z, Zhang H, Rong G, Bian S, Sawan M J Immunol Res. 2024; 2024:2313062.

PMID: 38268531 PMC: 10807946. DOI: 10.1155/2024/2313062.


The alterations of circulating mucosal-associated invariant T cells in polycystic ovary syndrome.

Zhou H, Xu J, Hong L, Jia Y, Burk L, Chi F Front Endocrinol (Lausanne). 2022; 13:1038184.

PMID: 36518256 PMC: 9742442. DOI: 10.3389/fendo.2022.1038184.


Mucosal-associated invariant T cells predict increased acute graft-versus-host-disease incidence in patients receiving allogeneic hematopoietic stem cell transplantation.

Wang Z, Zhang S, Zhang X, Liu L, Zhou L, Shen Y Cancer Cell Int. 2022; 22(1):297.

PMID: 36180885 PMC: 9526319. DOI: 10.1186/s12935-022-02703-x.